MPLN (MultiPlan) Valuation Rank

View and export this data going back to 2020. Start your Free Trial

What is MultiPlan Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

Three factors:
- Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
- Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
- Industry relative valuation
Companies without enough data is not ranked
Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

MultiPlan Valuation Rank Related Terms

Thank you for viewing the detailed overview of MultiPlan's Valuation Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

MultiPlan Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MultiPlan Corp (NYSE:MPLN) » Definitions » Valuation Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

115 Fifth Avenue, New York, NY, USA, 10003

Website

https://www.multiplan.us

MultiPlan Corp is a provider of data analytics and technology-enabled solutions designed to bring affordability, efficiency, and fairness to the U.S. healthcare industry. The company interprets clients' needs and customizes solutions that combine its payment integrity, network-based, and analytics-based services. The Company's focus is being a value-added provider of data analytics and technology-enabled end-to-end cost management, payment and revenue integrity solutions to the U.S. healthcare industry.

Executives

Michael Kim	officer: See Remarks	POLARIS PARENT CORP, 115 FIFTH AVENUE, NEW YORK NY 10003
Anthony Jr Colaluca	director	MULTIPLAN CORPORATION, 115 FIFTH AVENUE, NEW YORK NY 10003
John Michael Prince	director	115 FIFTH AVE., NEW YORK NY 10003
Nutter Carol	officer: SVP, Chief People Officer	115 FIFTH AVE., NEW YORK NY 10003
Mark Tabak	director, officer: Chief Executive Officer	115 FIFTH AVENUE, NEW YORK NY 10003
Michael K. Attal	director	425 PARK AVENUE, 30TH FLOOR, NEW YORK NY 10022
James M Head	officer: EVP & Chief Financial Officer	3001 COLORADO BLVD, DENTON TX 76210
Julie D Klapstein	director	1239 FRUIT COVE ROAD NORTH, JACKSONVILLE FL 32259
C Martin Harris	director
H&f Corporate Investors Viii, Ltd.	10 percent owner	415 MISSION STREET, SUITE 5700, SAN FRANCISCO CA 94105
Music Investments Gp, Llc	10 percent owner	C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Music Investments, L.p.	10 percent owner	C/O HELLMAN & FRIEDMAN, ONE MARTIME PLAZA, 12TH FLOOR, SAN FRANCISCO CA 94111
Glenn R August	director	C/O OHA - 1114 AVENUE OF THE AMERICAS, 27TH FLOOR, NEW YORK NY 10036
Paul Galant	officer: President, New Markets	88 WEST PLUMERIA DRIVE, SAN JOSE CA 95134
Michael Stuart Klein	director, 10 percent owner, officer: Chief Executive Officer	C/O DAVIS POLK & WARDWELL, 450 LEXINGTON AVENUE, NEW YORK NY 10017